Genetic Technologies Acquires EasyDNA from BelHealth
July 19, 2021
Genetic Technologies Limited (GENE/GTG) acquired the direct-to-consumer eCommerce business, brands and distribution rights of General Genetics Corporation trading as EasyDNA from BelHealth Investment Fund LP for US$4.0 million (cash, ADRs and escrow). The deal gives Genetic Technologies an established DTC genomics platform and distribution in ~40 countries (70+ websites) to accelerate its health & wellness and serious-disease test commercialisation and global expansion.
- Buyers
- Genetic Technologies Limited
- Targets
- EasyDNA (General Genetics Corporation)
- Sellers
- BelHealth Investment Fund LP
- Industry
- Biotechnology
- Location
- New Mexico, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Genetic Technologies Acquires AffinityDNA Direct-to-Consumer Business
July 14, 2022
Biotechnology
Genetic Technologies Limited (GENE) completed the acquisition of the direct-to-consumer eCommerce business and distribution rights of AffinityDNA, including websites, brand identities, laboratory testing and distribution agreements. The deal expands GENE’s direct-to-consumer channel and product portfolio across the US, UK and Europe, adding AffinityDNA’s consumer and pet genomics offerings to GENE’s geneType and EasyDNA brands.
-
Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)
October 4, 2022
Biotechnology
Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.
-
Eurofins to Acquire DNA Diagnostics Center (DDC) to Expand Consumer Genetic Testing
June 28, 2021
Biotechnology
Eurofins Scientific, via its subsidiary Eurofins Clinical Testing US Holdings, has entered into an agreement to acquire DNA Diagnostics Center (DDC), a consumer-focused DNA testing laboratory. The deal is expected to expand Eurofins’ reach into consumer genetics and health & wellness markets, with DDC projected to generate over $55M in 2021 revenue and operating from its Fairfield, Ohio facility.
-
Dotmatics Acquires SoftGenetics to Expand Genetic Analysis Capabilities
June 12, 2023
Software
Dotmatics has acquired SoftGenetics, a bioinformatics software company that provides genetic analysis tools for research, clinical, and forensic applications. The acquisition expands Dotmatics' R&D scientific software portfolio by adding SoftGenetics' suite of sequencing and genotyping products while allowing SoftGenetics to operate as a standalone business within Dotmatics.
-
GeneDx to Acquire Fabric Genomics
May 7, 2025
Healthcare Services
GeneDx announced it would acquire Fabric Genomics, an AI-powered genomic interpretation platform company, to enable decentralized testing powered by centralized intelligence. The deal expands GeneDx’s capabilities in NICU genomic testing and genomic newborn screening and targets global delivery of genomic insights.
-
Novacyt Acquires Yourgene Health plc
September 8, 2023
Medical Devices
Novacyt, through its wholly-owned subsidiary Novacyt UK Holdings Limited, has completed the acquisition of Yourgene Health plc by way of a court-sanctioned scheme of arrangement. The deal brings together Novacyt's diagnostics capabilities with Yourgene's genomic technologies and services to create a larger, diversified international molecular diagnostics business headquartered in Manchester, UK.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.